Russell Investments Group’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $571 | Buy |
+55
| New | +$571 | ﹤0.01% | 3734 |
|
|
2024
Q3 | – | Sell |
-152
| Closed | -$4.11K | – | 3785 |
|
|
2024
Q2 | $4.11K | Buy |
152
+145
| +2,071% | +$3.92K | ﹤0.01% | 3258 |
|
|
2024
Q1 | $137 | Hold |
7
| – | – | ﹤0.01% | 3290 |
|
|
2023
Q4 | $145 | Sell |
7
-564
| -99% | -$11.7K | ﹤0.01% | 3189 |
|
|
2023
Q3 | $18.2K | Sell |
571
-979
| -63% | -$31.1K | ﹤0.01% | 2900 |
|
|
2023
Q2 | $52.1K | Buy |
1,550
+56
| +4% | +$1.88K | ﹤0.01% | 2719 |
|
|
2023
Q1 | $62.3K | Sell |
1,494
-31
| -2% | -$1.29K | ﹤0.01% | 2680 |
|
|
2022
Q4 | $51.7K | Sell |
1,525
-37
| -2% | -$1.25K | ﹤0.01% | 2735 |
|
|
2022
Q3 | $76K | Sell |
1,562
-290
| -16% | -$14.1K | ﹤0.01% | 2706 |
|
|
2022
Q2 | $72K | Sell |
1,852
-462
| -20% | -$18K | ﹤0.01% | 2704 |
|
|
2022
Q1 | $84K | Sell |
2,314
-1,701
| -42% | -$61.7K | ﹤0.01% | 2585 |
|
|
2021
Q4 | $391K | Sell |
4,015
-2,552
| -39% | -$249K | ﹤0.01% | 2520 |
|
|
2021
Q3 | $817K | Sell |
6,567
-3,028
| -32% | -$377K | ﹤0.01% | 2275 |
|
|
2021
Q2 | $1.2M | Sell |
9,595
-955
| -9% | -$120K | ﹤0.01% | 2223 |
|
|
2021
Q1 | $1.43M | Buy |
10,550
+6,411
| +155% | +$869K | ﹤0.01% | 2070 |
|
|
2020
Q4 | $376K | Buy |
4,139
+3,861
| +1,389% | +$351K | ﹤0.01% | 2542 |
|
|
2020
Q3 | $20K | Hold |
278
| – | – | ﹤0.01% | 3137 |
|
|
2020
Q2 | $23K | Buy |
+278
| New | +$23K | ﹤0.01% | 3047 |
|